Vaccine design, formulation and regimes that induce antibody responses consisting predominantly of IgG1 and IgM are more likely to elicit bactericidal antibodies which can counter bacteremia, while IgA induction is likely to be important for preventing the initial invasion from the gastrointestinal tract. The gene discussed is CD79A; the disease is bacterial infectious disease with sepsis.